中國人壽AH齊漲 漲幅均超漲4%
格隆匯7月7日丨中國人壽AH今日雙雙大漲,目前漲幅均超4%,H股創今年1月底以來新高,A股創2015年5月以來新高。格隆匯平台昨日推出深度文章《當前時點,為什麼要重倉中國人壽(2628.HK)?》指出,中國人壽的基本面絕佳,投資收益在牛市中可以給出很高的預期,流動盤小資金喜歡追,綜合這些邏輯,人壽會在此輪牛市中走出很牛的行情。中國人壽A股目前只有0.8倍PEV,港股更是僅為0.5倍PEV,屬於明顯的低估。詳情可點擊下列鏈接瞭解。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.